Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,620
Total Claims
$1.6M
Drug Cost
372
Beneficiaries
$4,360
Cost/Patient
Risk Score Breakdown 18/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+218%
Opioid rate vs peers
8.2% vs 2.6% avg
+308%
Cost per patient vs peers
$4,360 vs $1,068 avg
+73%
Brand preference vs peers
15.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 218% above Family Practice peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
8.2%
Opioid Rate
870
Opioid Claims
$27K
Opioid Cost
6.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,635 claims · $1.3M
Generic: 8,841 claims · $284K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 136 | $170K |
| Tirzepatide | 137 | $160K |
| Apixaban | 55 | $69K |
| Insulin Aspart | 25 | $54K |
| Empagliflozin | 36 | $52K |
| Semaglutide | 22 | $50K |
| Dulaglutide | 34 | $49K |
| Rivaroxaban | 43 | $42K |
| Liraglutide | 26 | $42K |
| Fluticasone/Umeclidin/Vilanter | 28 | $39K |
| Linaclotide | 28 | $36K |
| Insulin Aspart | 16 | $35K |
| Insulin Pump Cart,automated,bt | 32 | $28K |
| Cariprazine Hcl | 15 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 28 | $27K |
Prescribing Profile
Patient Profile
68
Avg Age
65%
Female
1.35
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data